Understanding Weight Gain, Fat Storage, and Why It Matters

I'm Dr. William Summers, and I created this educational video series to help people better understand weight gain and its management. These videos are not selling anything and do not ask viewers to sign up for anything. They were created to simplify complex medical concepts and offer clarity around evidence-based recommendations and options that may support healthier lifestyles and a higher quality of life.

There are now more than 200 diseases associated with obesity, and to understand why, we need to start with how the body handles food.

Every time we eat a meal, our body uses some of those nutrients immediately for energy, and it stores some as fat to be used later. This is normal and necessary. In fact, women are biologically designed to carry a higher percentage of body fat than men—approximately 25–30% in women and 15–20% in men.

The soft, white fat under our skin—called subcutaneous fat—serves as an energy reserve between meals. These fat cells, known as adipocytes, fill with stored energy and later release it when the body converts fat back into usable fuel.

Each adipocyte can only hold so much fat. When it reaches capacity, new fat cells are created. This process, called hyperplasia, increases the number of fat cells under the skin. However, there is a limit to how many fat cells can be formed in this subcutaneous space. Once that limit is reached and the cells are full, any excess fat must be stored elsewhere.

Inside the abdominal cavity, surrounding our organs, we have a soft, elastic cushioning tissue called areolar connective tissue. These cells were once thought to be "empty," but they are actually a preferred site for excess fat storage when subcutaneous capacity is exceeded.

Unlike fat cells under the skin, these internal fat cells grow by hypertrophy, meaning they simply get larger and larger as they fill with fat. This difference explains why subcutaneous fat appears white, while internally stored fat often appears yellow and dense.

In the mid-1990s, researchers discovered that fat cells are not biologically inactive. They contain hormones—most notably leptin, which plays a critical role in appetite regulation and metabolism. This discovery transformed our understanding of fat tissue, revealing it to be an active part of the endocrine system.

Today, we know that fat cells produce hundreds of signaling chemicals, many of which communicate directly with the brain and immune system. Some researchers believe these cells evolved to maintain sophisticated communication pathways essential for survival.

The term "adiposopathy" is used to describe the diseases that arise when excess fat is stored in these internal abdominal cells. These cells produce compounds that influence:

• cancer development,
• endocrine function,
• immune regulation,
• and inflammatory processes.

I often think of these cells as the "Guardians of the Body's Galaxy." Under normal conditions, they protect us. But when they become overloaded with fat, their signals are disrupted.

Imagine elite swimmers lined up in their lanes, ready to race—but crude motor oil is poured into the pool. The lanes stretch, resistance increases, and performance suffers. The swimmers haven't changed—the environment has.

Obesity creates a similar internal environment.

As obesity rates have risen—now affecting roughly 40% of adults—we've seen parallel increases in cancers, autoimmune diseases, endocrine disorders, and inflammatory conditions. These changes are not coincidence.

For example, when someone with obesity experiences knee pain, it's often assumed that extra weight alone is stressing the joint. While mechanical load plays a role, the larger contributor is frequently disrupted inflammatory signaling from fat-derived hormones that can no longer move efficiently through fat-crowded tissue.

These internal fat cells also affect our organs directly. When fat accumulates around the liver, imaging may reveal what was once called "fatty liver disease," now known as metabolic-associated steatohepatitis (MASH). Mild elevations in liver enzymes—particularly when ALT is higher than AST—may warrant further evaluation such as ultrasound.

In early stages, this condition is reversible with weight loss. If it progresses, inflammation can lead to fibrosis and eventually cirrhosis. Today, obesity has surpassed alcohol as the most common cause of cirrhosis.

The same principles apply to the heart and other organs.

For overall health and quality of life, I recommend the following waist circumference targets:

• Men: under 40 inches
• Women: under 35 inches

(These thresholds vary for some Asian populations.)

I have much more to share about weight-management treatments, including medications, and the broader societal issues surrounding obesity care. Just as important, we must continue educating the public that obesity is a chronic medical disease—one that deserves the same seriousness, research investment, and insurance coverage as other long-term conditions.

At the same time, this must always be emphasized:

Every individual is inherently valuable and deserving of respect, dignity, and equality.

No one needs to lose weight to be worthy of respect or to be a better person.

Our focus must remain on education, transparency, fairness, and access to informed choices—free from stigma, bias, and misinformation—so people can make personal health decisions that support their well-being and quality of life.